Welcome to our dedicated page for GABY news (Ticker: GABLF), a resource for investors and traders seeking the latest updates and insights on GABY stock.
GABY Inc. (OTC: GABLF | CSE: GABY) provides centralized access to official corporate communications during its operational wind-down. This resource aggregates material developments including financial restructuring progress, leadership changes, and strategic evaluations of its CBD business units.
Investors will find verified updates regarding:
• Corporate restructuring milestones
• Regulatory filings and compliance matters
• CBD brand viability assessments
• Exchange compliance updates
All content derives from authorized company disclosures and regulatory submissions. For historical context, the page maintains records of past press releases detailing the California license impairment and subsequent foreclosure agreements.
Bookmark this page for direct access to GABY's evolving corporate narrative. Cross-reference announcements with SEDAR filings using provided documentation links. Contact investor relations at IR@GABYinc.com for clarification on published materials.
GABY Inc. (CSE:GABY)(OTCQB:GABLF) has successfully completed its merger with Miramar Professional Services, operator of the Mankind Dispensary. The merger, which was first announced in late 2020, enables GABY to expand its retail presence and integrate its proprietary products with Mankind's offerings. Mankind reported revenues of C$39.1 million and EBITDA of C$7.0 million for the fiscal year 2020. Trading of GABY shares will resume on April 23, 2021, following final approval from the CSE. Key personnel changes include Margot Micallef as CEO of the combined company.
GABY Inc. (CSE:GABY)(OTCQB:GABLF) announced a definitive agreement for a merger with Miramar Professional Services, operators of Mankind Dispensary, effective February 15, 2021. This merger is classified as a 'fundamental change', resulting in a halt of GABY's shares on the Canadian Stock Exchange until completion. Shareholder and CSE approvals are needed, with over 50% support already confirmed. GABY aims to become a significant player in California's cannabis retail market by leveraging synergies from the merger.
GABY Inc. (CSE: GABY, OTCQB: GABLF) has completed a brokered and non-brokered private placement, raising C$12.5 million to fund its merger with Miramar Professional Services, operator of Mankind Dispensary. This merger marks GABY's entry into cannabis retail. The company has received shareholder support for the merger, with over 50% approval. Additionally, the audit of Miramar is complete, further solidifying the merger process. GABY aims to leverage Mankind's reputation to enhance its retail strategy in California's competitive cannabis market.
GABY Inc. (CSE:GABY, OTCQB:GABLF) reported its Q2 2020 results, showcasing a variable gross margin of 23%, significantly up from 11% in Q2 2019 and negative 1.0% in Q1 2020. However, revenue decreased to $0.7 million from $2.1 million year-over-year. Adjusted EBITDA from continuing operations improved by $1.9 million to ($1.6 million), primarily due to lower SG&A expenses. Management anticipates annualized savings of approximately $6 million from its restructuring efforts aimed at long-term profitability.
GABY Inc. (CSE:GABY, OTCQB:GABLF) reports strong growth with 2019 revenues of $11.9 million, a remarkable 395% increase from 2018. Despite operational challenges, Q1 2020 revenue rose to $1.4 million compared to $0.054 million in Q1 2019. The company underwent a management restructuring and closed its less profitable food segment, yielding $5 million in annual savings. Future goals include achieving cash flow positivity by the end of 2020 through operational efficiencies and high-margin revenue generation.
